Technical Analysis for RVX - Resverlogix Corp.

Grade Last Price % Change Price Change
grade D 0.76 1.33% 0.010
RVX closed up 1.33 percent on Thursday, August 6, 2020, on 40 percent of normal volume. It was able to find support at its 50 day moving average.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Up Down
Historical RVX trend table...

Date Alert Name Type % Chg
50 DMA Support Bullish 0.00%
Crossed Above 20 DMA Bullish 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
Crossed Above 50 DMA Bullish 1.33%
Expansion Pivot Buy Setup Bullish Swing Setup 1.33%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 1.33%
Pocket Pivot Bullish Swing Setup 1.33%
Bollinger Band Squeeze Range Contraction 1.33%
BB Squeeze + Lower Band Touch Range Contraction 1.33%
Outside Day Range Expansion 1.33%

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Resverlogix Corp. is a clinical-stage biotechnology company. The Company is a development-stage company, which is engaged in developing apabetalone (RVX-208), a first-in-class small molecule selective Bromodomain and ExtraTerminal domain (BET) inhibitor. Apabetalone is used for the treatment of patients with high-risk cardiovascular disease, (including peripheral arterial disease), diabetes mellitus, chronic kidney disease, Alzheimer's disease and orphan diseases. Apabetalone is being investigated in a Phase III clinical trial for the secondary prevention of major adverse cardiovascular events (MACE) in high risk patients with diabetes mellitus and chronic kidney disease. The Company initiated a Phase III clinical trial BETonMACE with apabetalone in high-risk cardiovascular disease patients with low high-density lipoprotein. It focuses on conducting a proof-of-concept clinical trial in patients with Paroxysmal Nocturnal Hemoglobinuria. The Company has not generated any revenues.
Medicine Medical Specialties Biotechnology RTT Alzheimer's Disease Chronic Condition Diabetes Mellitus

Is RVX a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 3.04
52 Week Low 0.35
Average Volume 86,103
200-Day Moving Average 1.050
50-Day Moving Average 0.739
20-Day Moving Average 0.758
10-Day Moving Average 0.764
Average True Range 0.040
ADX 9.55
+DI 19.796
-DI 24.006
Chandelier Exit (Long, 3 ATRs ) 0.701
Chandelier Exit (Short, 3 ATRs ) 0.819
Upper Bollinger Band 0.803
Lower Bollinger Band 0.712
Percent B (%b) 0.53
BandWidth 12.040
MACD Line 0.000
MACD Signal Line 0.002
MACD Histogram -0.0022
Fundamentals Value
Market Cap 87.11 Million
Num Shares 115 Million
EPS -0.52
Price-to-Earnings (P/E) Ratio -1.46
Price-to-Sales 0.00
Price-to-Book 0.00
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.805
Resistance 3 (R3) 0.800 0.780 0.798
Resistance 2 (R2) 0.780 0.769 0.783 0.795
Resistance 1 (R1) 0.770 0.761 0.775 0.775 0.792
Pivot Point 0.750 0.750 0.753 0.753 0.750
Support 1 (S1) 0.740 0.739 0.745 0.745 0.728
Support 2 (S2) 0.720 0.731 0.723 0.725
Support 3 (S3) 0.710 0.720 0.723
Support 4 (S4) 0.715